![David A. Benaron](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David A. Benaron
Gründer bei Vital Insite, Inc.
Aktive Positionen von David A. Benaron
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The International Society for Optical Engineering
![]() The International Society for Optical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Optical Engineering operates as society for optics and photonics. It advances emerging technologies through interdisciplinary information exchange, continuing education, publications, patent precedent, and career and professional growth. The company was founded on July 1, 1955 and is headquartered in Bellingham, WA. | Corporate Officer/Principal | - | - |
Xenogen Corp.
![]() Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Gründer | 19.08.2009 | - |
Vital Insite, Inc. | Gründer | 19.08.2009 | - |
Firstscan Corp. | Gründer | 14.05.2010 | - |
Insite, Inc. | Gründer | 14.05.2010 | - |
Karriereverlauf von David A. Benaron
Ehemalige bekannte Positionen von David A. Benaron
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Spectros Corp.
![]() Spectros Corp. Medical SpecialtiesHealth Technology Spectros Corp. develops, markets, and licenses medical devices based on in vivo molecular optical technologies, including clinical devices for detection of ischemia and cancer. Its medical devices utilize optical technologies that speed diagnosis, enable real-time therapies and reduce complications. The company's flagship product, the T-Stat Tissue Oximeter, is a medical device that is sensitive to ischemia, an insufficient supply of oxygen to tissue. The firm is also developing molecular imaging contrast agents for surgical guidance during breast and prostate cancer surgeries. Spectros was incorporated on April 19, 1995 and is headquartered in Portola Valley, CA. | Vorstandsvorsitzender | - | - |
Gründer | 19.08.2009 | - |
Ausbildung von David A. Benaron
Harvard University | Doctorate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
University of California, Berkeley | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Operativ
Founder | 5 |
Undergraduate Degree | 3 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Xenogen Corp.
![]() Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Health Technology |
The International Society for Optical Engineering
![]() The International Society for Optical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Optical Engineering operates as society for optics and photonics. It advances emerging technologies through interdisciplinary information exchange, continuing education, publications, patent precedent, and career and professional growth. The company was founded on July 1, 1955 and is headquartered in Bellingham, WA. | Commercial Services |
Spectros Corp.
![]() Spectros Corp. Medical SpecialtiesHealth Technology Spectros Corp. develops, markets, and licenses medical devices based on in vivo molecular optical technologies, including clinical devices for detection of ischemia and cancer. Its medical devices utilize optical technologies that speed diagnosis, enable real-time therapies and reduce complications. The company's flagship product, the T-Stat Tissue Oximeter, is a medical device that is sensitive to ischemia, an insufficient supply of oxygen to tissue. The firm is also developing molecular imaging contrast agents for surgical guidance during breast and prostate cancer surgeries. Spectros was incorporated on April 19, 1995 and is headquartered in Portola Valley, CA. | Health Technology |
Vital Insite, Inc. | |
Insite, Inc. | |
Firstscan Corp. |
- Börse
- Insiders
- David A. Benaron
- Erfahrung